ReviewInternational journal of nanomedicine2025
Deep Eutectic Solvents in Chronic Wound Management: Current Developments and Future Prospects.
Review in International journal of nanomedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Advancements in Therapeutic Deep Eutectic Solvents as Multifunctional Transdermal Delivery Systems.Pharmaceutics · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic wounds pose a significant and growing global health challenge, affecting millions of individuals and often leading to prolonged suffering and increased healthcare costs. A major barrier to effective healing is wound infection, which disrupts the natural repair process and contributes to the chronicity. Therefore, innovative strategies for infection control are urgently required. Deep Eutectic Solvents (DESs) have recently gained attention as promising drug delivery systems owing to their multifunctional properties. In addition to serving as penetration enhancers that improve drug permeation, DESs exhibit intrinsic antimicrobial and antibiofilm activities, making them attractive candidates for managing infected wounds. This review highlights the fundamentals of DESs in the context of chronic wound management. It provides an overview of the wound healing process, pathophysiology of chronic wounds, and the role of biofilms in persistent infections. It further explores the dual role of DESs as penetration enhancers and antibiofilm agents, summarizing the recent DES-based formulations under investigation. Finally, this review discusses the current challenges and future prospects of integrating DESs into clinical practice. Collectively, DESs represent novel and versatile therapeutic platforms that have the potential to transform the treatment landscape of chronic wound healing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.